Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Eltrombopag (50mg) Tablet
Therapeutic Category
Immunology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10x10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Eltrombopag 50 mg Tablet is a thrombopoietin receptor agonist indicated for the management of chronic immune thrombocytopenia (ITP) and thrombocytopenia associated with chronic hepatitis C. It supports an increase in platelet count and helps reduce the risk of bleeding.
The medication works by stimulating thrombopoietin receptors in the bone marrow, promoting platelet production without suppressing immune function. This targeted action makes it suitable for patients requiring controlled platelet elevation.
Clinically, Eltrombopag 50 mg Tablet is prescribed for patients with persistently low platelet counts who do not respond adequately to first-line therapies, supporting stable hematological outcomes under specialist supervision.
With its importance in long-term hematology treatment and consistent prescription demand, this therapy helps strengthen specialty medicine portfolios and supports sustained growth by addressing critical platelet management needs in clinical practice.
Common side effects may include headache, nausea, diarrhea, fatigue, and upper respiratory tract infections. Rarely, elevated liver enzymes, thromboembolic events, or cataract formation may occur.
Eltrohype 50 Tablet is indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It is also used in thrombocytopenia associated with chronic hepatitis C and severe aplastic anemia as prescribed by a physician.
Use this medicine strictly under medical supervision. Regular monitoring of platelet count and liver function tests is essential during treatment. Do not exceed the recommended dosage. Inform the doctor about any history of liver disease or clotting disorders.
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.
Composition : Faropenem (200mg)
Composition : Faropenem (300mg) Tablet
Composition : Levofloxacin (250mg) Tablet
Composition : Levofloxacin (250mg) + Ornidazole (500mg)
Composition : Levofloxacin (500mg)
Composition : Levofloxacin (750mg)
Composition : Moxifloxacin (400mg)
Composition : Nitrofurantoin (100mg) Tablet
Composition : Norfloxacin (400mg) + Tinidazole (600mg)
Composition : Ofloxacin (200mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Eltrombopag 50mg Tablet is a specialty hematology medicine widely used in platelet disorder management, making it a high-value prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from demand in thrombocytopenia management, low platelet count disorders, chronic immune thrombocytopenic purpura (ITP), platelet support therapy, and hematology care. It is commonly prescribed by hematologists and specialty physicians for long-term platelet management treatment.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Eltrombopag 50mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from specialty prescription demand, hospital and clinic supply opportunities, and growing acceptance in hematology care segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this hematology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.